7. Diabetes Technology: Standards of Medical Care in Diabetes—2022

Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear

(2021) Tiffany Yeh et al.   Current Diabetes Reports

Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy

(2021) Rogério Tavares Ribeiro et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

(2021) Georgia M. Davis et al.   DIABETES CARE

Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data

(2021) Jerzy Hohendorff et al.   Diabetes Technology & Therapeutics

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

(2021) David Nathanson et al.   DIABETOLOGIA

Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting with Continuous Glucose Monitoring: FUTURE-PEAK

(2021) Ben Broos et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study

(2021) Tom Elliott et al.   Diabetes & Vascular Disease Research

Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters

(2021) Annel Lameijer et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

(2021) Thomas Martens et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes

(2021) Andrew J. Karter et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

(2021) Margaretha M Visser et al.   LANCET

Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial

(2021) Rafael Vaz Machry et al.   Diabetology & Metabolic Syndrome

Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

(2021) David A. Price et al.   Diabetes Therapy

The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes

(2021) Heather Ulrich et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Randomized Controlled Trial of Mobile Closed-Loop Control

(2020) Boris Kovatchev et al.   DIABETES CARE

Efficacy of Insulclock in patients with poorly controlled type 1 diabetes mellitus: a pilot, randomized clinical trial

(2020) Fernando Gómez Peralta et al.   Diabetes Technology & Therapeutics

Effect of a Mobile Phone–Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled Trial

(2020) Yeoree Yang et al.   JMIR mHealth and uHealth

Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis?

(2020) Anne Herman et al.   CONTACT DERMATITIS

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

(2020) Sue A. Brown et al.   DIABETES CARE

Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue

(2020) Fortunato Lombardo et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The Do-It-Yourself Artificial Pancreas: A Comprehensive Review

(2020) Jothydev Kesavadev et al.   Diabetes Therapy

Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit

(2020) Harshal Deshmukh et al.   DIABETES CARE

Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Control: A Randomized Controlled Trial

(2020) Sara E. Boucher et al.   DIABETES CARE

Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes

(2020) Emi Ushigome et al.   Diabetes Technology & Therapeutics

Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry

(2020) Dirk Sandig et al.   Diabetes Technology & Therapeutics

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes

(2020) Richard E. Pratley et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes

(2020) Lori M. Laffel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance

(2020) Ananta Addala et al.   PEDIATRIC DIABETES

Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial

(2020) Eri Wada et al.   BMJ Open Diabetes Research & Care

Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial

(2020) Aneta Hásková et al.   DIABETES CARE

The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

(2020) Moshe Phillip et al.   Diabetes Technology & Therapeutics

Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well‐controlled youth with type 1 diabetes

(2020) Sara Charleer et al.   PEDIATRIC DIABETES

Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study

(2020) Carolina Piras de Oliveira et al.   CURRENT MEDICAL RESEARCH AND OPINION

A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes

(2020)   DIABETES CARE

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

(2020) Shivani Agarwal et al.   DIABETES CARE

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial

(2019) Richard M Bergenstal et al.   LANCET

Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies

(2019) Karl Kristensen et al.   DIABETOLOGIA

Text-message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes

(2019) D. E. McGill et al.   DIABETIC MEDICINE

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial

(2019) Gregory P. Forlenza et al.   Diabetes Technology & Therapeutics

Using Digital Health Technology to Prevent and Treat Diabetes

(2019) Neal Kaufman et al.   Diabetes Technology & Therapeutics

Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes

(2019) Marianna Yaron et al.   DIABETES CARE

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

(2019) Richard M. Bergenstal et al.   Diabetes Technology & Therapeutics

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia

(2019) Stacey M. Anderson et al.   Diabetes Technology & Therapeutics

Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients

(2019) Heli S. I. Hyry et al.   CONTACT DERMATITIS

Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial

(2019) Ramzi A Ajjan et al.   Diabetes & Vascular Disease Research

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature

(2019) Stefan Pleus et al.   Diabetes Technology & Therapeutics

Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus

(2019) Susana R. Patton et al.   Diabetes Technology & Therapeutics

Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis

(2019) Harsahiba Kaur et al.   Diabetes Technology & Therapeutics

Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes

(2019) Victoria Tyndall et al.   DIABETOLOGIA

The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy

(2019) Eva Oppel et al.   CONTACT DERMATITIS

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop

(2019) Rayhan A. Lal et al.   DIABETES CARE

CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time

(2019) Priya Prahalad et al.   DIABETES CARE

Real-World Safety of an Implantable Continuous Glucose Sensor over Multiple Cycles of Use: A Post-Market Registry Study

(2019) Dorothee Deiss et al.   Diabetes Technology & Therapeutics

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor

(2019) Patricia Sanchez et al.   Diabetes Technology & Therapeutics

Reviewing U.S. Connected Diabetes Care: The Newest Member of the Team

(2019) Brian J. Levine et al.   Diabetes Technology & Therapeutics

Efficacy of intermittently scanned continuous glucose monitoring in the prevention of recurrent severe hypoglycemia

(2019) Timothy Davis et al.   Diabetes Technology & Therapeutics

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions

(2019) Jennifer L. Sherr et al.   Diabetes Technology & Therapeutics

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

(2019) Sara Charleer et al.   DIABETES CARE

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

(2019) G. Alexander Fleming et al.   DIABETES CARE

Accuracy of a blood glucose monitoring system that recognizes insufficient sample blood volume and allows application of more blood to the same test strip

(2019) Bern Harrison et al.   Expert Review of Medical Devices

Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors

(2018) Maria Jose Redondo et al.   DIABETES CARE

Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital

(2018) Guillermo E. Umpierrez et al.   DIABETES CARE

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors

(2018) David C. Klonoff et al.   DIABETES CARE

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus

(2018) Marc D. Breton et al.   Diabetes Technology & Therapeutics

C-PEPTIDE AND BETA-CELL AUTOANTIBODY TESTING PRIOR TO INITIATING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) PUMP THERAPY DID NOT IMPROVE UTILIZATION OR MEDICAL COSTS AMONG OLDER ADULTS WITH DIABETES MELLITUS (DM)

(2018) Max Gill et al.   Endocrine Practice

IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS

(2018) Robert A. Vigersky et al.   Endocrine Practice

Effectiveness of Internet-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials

(2018) Ying Shen et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial

(2018) Lutz Heinemann et al.   LANCET

Remote Lifestyle Coaching Plus a Connected Glucose Meter with Certified Diabetes Educator Support Improves Glucose and Weight Loss for People with Type 2 Diabetes

(2018) Jennifer B. Bollyky et al.   Journal of Diabetes Research

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial

(2018) Gregory P. Forlenza et al.   DIABETES CARE

Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting

(2018) Eric Renard et al.   DIABETES OBESITY & METABOLISM

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch

(2018) Michael P. Stone et al.   Diabetes Technology & Therapeutics

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes

(2018) Bruce A. Buckingham et al.   Diabetes Technology & Therapeutics

Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes

(2018) Pilar Isabel Beato-Víbora et al.   Diabetes Technology & Therapeutics

App-Based Insulin Calculators: Current and Future State

(2018) Leslie Eiland et al.   Current Diabetes Reports

In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes

(2018) Michael A. Wood et al.   Diabetes Technology & Therapeutics

Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity

(2018) Lenka Petruzelkova et al.   Diabetes Technology & Therapeutics

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

(2018) Gregory P. Forlenza et al.   Diabetes Technology & Therapeutics

A Review of Blood Glucose Monitor Accuracy

(2018) Fraya King et al.   Diabetes Technology & Therapeutics

A Pilot Study of Use of a Software Platform for the Collection, Integration, and Visualization of Diabetes Device Data by Health Care Providers in a Multidisciplinary Pediatric Setting

(2018) Jenise C. Wong et al.   Diabetes Technology & Therapeutics

Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes

(2018) Tien-Ming Hng et al.   INTERNAL MEDICINE JOURNAL

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

(2018) Martin Tauschmann et al.   LANCET

Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis

(2018) Vasilios Karageorgiou et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice

(2017) Timothy S. Bailey et al.   Expert Opinion on Drug Delivery

Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes

(2017) Beate Karges et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

(2017) Marcus Lind et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

(2017) Roy W. Beck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

FreeStyle Libre: contact irritation versus contact allergy

(2017) Olivier Aerts et al.   LANCET

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

(2017) Denice S Feig et al.   LANCET

Managing diabetes in preschool children

(2017) Frida Sundberg et al.   PEDIATRIC DIABETES

Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings

(2017) Laura A. Young et al.   JAMA Internal Medicine

Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections

(2017) Tonya Riddlesworth et al.   Diabetes Therapy

Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections

(2017) Tonya Riddlesworth et al.   Diabetes Therapy

Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting

(2016) Alda Troncone et al.   DIABETES CARE

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

(2016) Richard M. Bergenstal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

(2016) Anne L. Peters et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

(2016) Jan Bolinder et al.   LANCET

New Insulin Delivery Recommendations

(2016) Anders H. Frid et al.   MAYO CLINIC PROCEEDINGS

Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases

(2016) Aveni Haynes et al.   PEDIATRIC DIABETES

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial

(2016) Cornelis A J van Beers et al.   Lancet Diabetes & Endocrinology

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

(2016) Thomas Haak et al.   Diabetes Therapy

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

(2016) Thomas Haak et al.   Diabetes Therapy

Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality

(2016) Bedowra Zabeen et al.   PLoS One

Effect of a CGMS and SMBG on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus: a Randomized Controlled Trial

(2016) Qiong WEI et al.   Scientific Reports

Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes

(2015) S. Lane Slabaugh et al.   ADVANCES IN THERAPY

Smartphone apps for calculating insulin dose: a systematic assessment

(2015) Kit Huckvale et al.   BMC Medicine

Rates of Diabetic Ketoacidosis: International Comparison With 49,859 Pediatric Patients With Type 1 Diabetes From England, Wales, the U.S., Austria, and Germany

(2015) David M. Maahs et al.   DIABETES CARE

Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial

(2015) Andrea Tumminia et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)

(2015) J. P. New et al.   DIABETIC MEDICINE

Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries

(2015) Jennifer L. Sherr et al.   DIABETOLOGIA

Racial-Ethnic Disparities in Management and Outcomes Among Children With Type 1 Diabetes

(2015) S. M. Willi et al.   PEDIATRICS

Dual Use of Department of Veterans Affairs and Medicare Benefits and Use of Test Strips in Veterans With Type 2 Diabetes Mellitus

(2015) Walid F. Gellad et al.   JAMA Internal Medicine

Translating the Diabetes Prevention Program into an Online Social Network

(2014) S. Cameron Sepah et al.   DIABETES EDUCATOR

Insulin Pump–Associated Adverse Events in Children and Adolescents—A Prospective Study

(2014) Benjamin J. Wheeler et al.   Diabetes Technology & Therapeutics

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

(2014) Yves Reznik et al.   LANCET

Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years

(2014) Jenise C Wong et al.   PEDIATRIC DIABETES

Meta-analysis: Self-monitoring in non–insulin-treated type 2 diabetes improved HbA1cby 0.25%

(2013) Laura Rees Willett   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus

(2013) Hsin-Chieh Yeh et al.   ANNALS OF INTERNAL MEDICINE

Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials

(2013) Carl V. Asche et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes: A randomized controlled trial

(2013) A. L. Secher et al.   DIABETES CARE

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes

(2013) J. L. Sherr et al.   DIABETES CARE

Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

(2013) K. M. Miller et al.   DIABETES CARE

Treat-to-target trials: uses, interpretation and review of concepts

(2013) A. J. Garber   DIABETES OBESITY & METABOLISM

Continuous Glucose Monitoring Pilot in Low-Income Type 1 Diabetes Patients

(2013) Paola A. Sequeira et al.   Diabetes Technology & Therapeutics

Race, Socioeconomic Status, and Treatment Center Are Associated with Insulin Pump Therapy in Youth in the First Year Following Diagnosis of Type 1 Diabetes

(2013) Maria H. Lin et al.   Diabetes Technology & Therapeutics

Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes

(2013) Andrew Ahmann et al.   Diabetes Technology & Therapeutics

Effect of Glargine Insulin Delivery Method (Pen Device Versus Vial/Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes

(2013) Stacey Seggelke et al.   Endocrine Practice

Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis

(2013) Maria J Redondo et al.   PEDIATRIC DIABETES

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study

(2013) Elizabeth L. Eby et al.   JOURNAL OF MEDICAL ECONOMICS

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

(2012) T. Battelino et al.   DIABETOLOGIA

Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy

(2012) Olga Kordonouri et al.   PEDIATRIC DIABETES

Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program study

(2011) W. H. Polonsky et al.   DIABETES CARE

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

(2011) T. Battelino et al.   DIABETES CARE

Insulin delivery by injection in children and adolescents with diabetes

(2011) Ragnar Hanas et al.   PEDIATRIC DIABETES

Health Economics and Compliance of Vials/Syringes Versus Pen Devices: A Review of the Evidence

(2010) Carl V. Asche et al.   Diabetes Technology & Therapeutics

Dosing Accuracy of Insulin Pens Versus Conventional Syringes and Vials

(2010) Y.M. Luijf et al.   Diabetes Technology & Therapeutics

Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes

(2010) Ralph Ziegler et al.   PEDIATRIC DIABETES

The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes

(2009)   DIABETES CARE

Comparative Device Assessments

(2009) Debra A. Ignaut et al.   DIABETES EDUCATOR

Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial

(2009) M. A. O’Connell et al.   DIABETOLOGIA

Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes

(2008) H.J. Yoo et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Severe hypoglycaemia and glycaemic control in Type1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

(2008) J. C. Pickup et al.   DIABETIC MEDICINE

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

(2008) K. Jeitler et al.   DIABETOLOGIA

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria

(2008) MA Berghaeuser et al.   PEDIATRIC DIABETES